期刊文献+

肿瘤标记物、超声检查在卵巢肿瘤诊断中的应用 被引量:14

下载PDF
导出
摘要 目的肿瘤标记物联合超声检查在良、恶性卵巢肿瘤诊断中的应用。方法选取140例卵巢肿瘤,行肿瘤标记物和超声检查,用放免法检测CA125、CA199、CA153,并将诊断结果与病理结果进行对照。结果肿瘤标记物联合阴道彩超对40例卵巢恶性肿瘤的诊断符合率97.5%,对交界性肿瘤的诊断率较低,对畸胎瘤的诊断符合率为75%,对卵巢巧克力囊肿的诊断符合率为80%。结论肿瘤标记物联合超声检查可以提高卵巢癌的诊断率。CA125对卵巢巧克力囊肿的阳性率高,CA199对卵巢畸胎瘤的阳性率高。
作者 吴俊改
出处 《现代中西医结合杂志》 CAS 2013年第8期877-879,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献5

二级参考文献15

  • 1徐文生,马燕.血清CA_(125)及多普勒超声检测在卵巢恶性肿瘤诊断中的应用[J].广西医科大学学报,2004,21(3):388-389. 被引量:2
  • 2[1]Meyer T, Rustin GJ. Role of tumour markers in monitoring epithelial ova rian cancer.Br J Cancer, 2000, 82(9):1535
  • 3[2]Rustin GJ, Nelstrop AE, Bentzen SM,et al. Selection of active drugs for ovari an cancer based on CA-125 and standard response rates in phase Ⅱ trials. J Clin Oncol, 2000, 18(8):1733
  • 4[3]Maggino T, Gadducci A.Serum markers as prognostic factors in epithelial ovari an cancer: an overview. Eur J Gynaecol Oncol, 2000,21(1):64
  • 5[4]Hensley ML, Castiel M, Robson ME. Screening for ovarian cancer: what we know, what we need to know. Oncology (Huntingt), 2000,14(11):1601
  • 6[6]Colakovic S, Lukic V, Mitrovic L, et al. Prognostic value of CA125 kinetics a nd half-life in advanced ovarian cancer. Int J Biol Markers, 2000,15(2):147
  • 7[9]Petignat P, Joris F, Obrist R. How CA 125 is used in routine clinical practic e. Eur J Cancer, 2000, 36(15):1933
  • 8[11]Jeyarajah AR, Ind TE, MacDonald N,et al. Increased mortality in postmenopausal women with serum CA125 elevation. Gynecol Oncol,1999, 73(2): 242
  • 9[14]Patsner B, Orr JW, Mann WJ. Use of serum CA125 measurement in post-trea tment surveillance of early-stage endometrial carcinoma. Am J Obstet Gynecol,19 90,162:427
  • 10孔秋英,谢红宁.妇产科影像学诊断与介入治疗学[M].第1版.北京:人民卫生出版社,1998,326~348.

共引文献638

同被引文献137

  • 1李珊.B超诊断卵巢肿瘤130例的体会[J].中国卫生产业,2012,9(28):154-154. 被引量:2
  • 2何建芳,罗淑贞,卢义生,赵东晖.3459例卵巢肿瘤病理统计分析[J].中国肿瘤,2006,15(5):309-311. 被引量:4
  • 3王泽华,汪洪波,沈怡,童晓文,王和,王建六,王志启.卵巢恶性上皮性肿瘤的诊断和处理[J].现代妇产科进展,2007,16(4):241-251. 被引量:8
  • 4齐铮琴,赵玉珍,杨漪,纪晓惠.经阴道彩色多普勒超声诊断卵巢良恶性肿瘤的价值[J].中国医学影像学杂志,2007,15(3):173-175. 被引量:18
  • 5穆玉兰,刘鸣,汤春生.卵巢癌筛查研究进展[J].中国实用妇科与产科杂志,2007,23(10):804-805. 被引量:10
  • 6Kulak A,Kupesic S,Anic T,et al.Three-dimcnsional uhrasound and power dop-pler improve the diagnosis of ovarian |esions[J].Gynecol Onco|,2000, 76(1):28-32.
  • 7Van Gorp T, Veldman J, Van Calster B, et al. Subjective as- sessment by ultrasound is superior to the risk of malignancy in- dex (RMI) or the risk of ovarian malignancy algorithm (RO- MA) in discriminating benign from malignant adnexal masses [J]. Eur J Cancer, 2012, 48 (11) : 1649-1656.
  • 8Gentry-Maharaj A, Menon U. Screening for ovarian cancer in the general population [ J]. Best Pract Res Clin Obstet Gynae- col, 2012, 26 (2): 243-256.
  • 9Paseual M, Graupera B, Hereter L, et al. 0C14. 01 : Early diagnosis in ovarian cancer: role of transvaginal color Doppler ultrasound. A fourteen year experience [ J ]. Ultrasound Obstet Gynecol, 2013, 42 (sl) : 27-27.
  • 10Kaijser J, Bourne T, Valentin L, et al. Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies [ J]. Ultrasound Ob- stet Gynecol, 2013, 41 (1) : 9-20.

引证文献14

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部